Farhana Merchant Malik, a partner in the firm’s Mumbai office, has boosted Dentons Link Legal’s real estate business.

State attorneys general (AGs), who have actively worked to close the vacuum created by weakened federal enforcement, are increasingly scrutinizing clients and posing a regulatory danger.

Jenny Choi, a resident of the London office, will become a partner at Sullivan & Cromwell LLP, the firm announced today.

Bryan Lowrance has joined Hogan Lovells as a partner in our Boston-based M&A practice area, the company announced today. He comes from Ropes & Gray.

When Riverarch Equity Partners, a Pittsburgh-based private equity firm that makes investments in distribution, food and beverage, business and consumer services, and specialty manufacturing companies in the US and Europe, acquired Walex Products Company, Inc., a market-leading cleaning and sanitation chemicals company with its headquarters located in Leland, North Carolina, K&L Gates LLP provided advice.

Envision Radiology received advice from BCLP regarding the acquisition of Rezolut Holdings, a national platform for diagnostic medical imaging services, as well as the related credit financing.

Cipher Mining Technologies Inc. sold its 49 percent stake in a joint venture for cryptocurrency mining to Canaan Inc. under the representation of Norton Rose Fulbright. The deal closed on February 18, 2026, and was estimated to be worth US$40 million.

Today, Norton Rose Fulbright Canada announced that Matthew Boswell has joined the firm as a partner in its Ottawa-based Antitrust and Competition group.

Gibson Dunn provided guidance to Thmanyah Publishing and Distribution Company (Thmanyah), a division of the Saudi Research and Media Group, about the signing of media rights contracts with the First Division League, the Saudi Professional League, and the Saudi Arabian Football Federation.

Akin helped Pharmakon Advisors, LP and its affiliated funds offer UroGen Pharma Ltd., a biotech business committed to creating and marketing cutting-edge treatments for urothelial other specialized malignancies, a senior secured term loan of up to $250 million in two tranches.